Abstract
Diabetes in pregnancy has important implications for both maternal and fetal health. The increasing prevalence of diabetes requires that providers caring for women of childbearing age understand how to counsel and manage women with diabetes. In women with type 1 and type 2 diabetes mellitus (DM), pregnancy outcome can be improved by pregestational intervention to insure euglycemia during conception and the embryonic period. In gravidas whose glucose intolerance is discovered during pregnancy [i.e., gestational diabetes (GDM)], glucose surveillance during pregnancy and diabetic and other metabolic screening following pregnancy positively impact fetal and maternal health. The aim of this chapter is to describe the effect of pregnancy on glucose metabolism, discuss the clinical importance of diabetes in pregnancy, summarize screening and diagnostic testing models for GDM, and highlight important clinical issues that impact on pregestational and gestational diabetes management.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
National Diabetes Statistics. National diabetes information clearinghouse. 2011. www.diabetes.niddk.nih.gov
Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87(1):4–14.
Hunt KJ, Schuller KL. The increasing prevalence of diabetes in pregnancy. Obstet Gynecol Clin North Am. 2007;34(2):173–99. vii.
Baraban E, McCoy L, Simon P. Increasing prevalence of gestational diabetes and pregnancy-related hypertension in Los Angeles County, California, 1991-2003. Prev Chronic Dis. 2008;5(3):A77.
Hypertension in pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; 2013.
Mills JL, Jovanovic L, Knopp R, Aarons J, Conley M, Park E, et al. Physiological reduction in fasting plasma glucose concentration in the first trimester of normal pregnancy: the diabetes in early pregnancy study. Metabolism. 1998;47(9):1140–4.
Chew EY, Mills JL, Metzger BE, Remaley NA, Jovanovic-Peterson L, Knopp RH, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes care. 1995;18(5):631–7.
Diabetes C. Complications Trial Research G. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes Care. 2000;23(8):1084–91.
Sheth BP. Does pregnancy accelerate the rate of progression of diabetic retinopathy? An update. Curr Diab Rep. 2008;8(4):270–3.
Jones DC, Hayslett JP. Outcome of pregnancy in women with moderate or severe renal insufficiency. N Engl J Med. 1996;335(4):226–32.
Epstein FH. Pregnancy and renal disease. N Engl J Med. 1996;335(4):277–8.
Gordon M, Landon MB, Samuels P, Hissrich S, Gabbe SG. Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy. Obstet Gynecol. 1996;87(3):401–9.
Ekbom P, Damm P, Feldt-Rasmussen B, Feldt-Rasmussen U, Molvig J, Mathiesen ER. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care. 2001;24(10):1739–44.
Guo RX, Yang LZ, Li LX, Zhao XP. Diabetic ketoacidosis in pregnancy tends to occur at lower blood glucose levels: case-control study and a case report of euglycemic diabetic ketoacidosis in pregnancy. J Obstet Gynaecol Res. 2008;34(3):324–30.
Cullen MT, Reece EA, Homko CJ, Sivan E. The changing presentations of diabetic ketoacidosis during pregnancy. Am J Perinatol. 1996;13(7):449–51.
Parker JA, Conway DL. Diabetic ketoacidosis in pregnancy. Obstet Gynecol Clin North Am. 2007;34(3):533–43. xii.
Greene MF. Prevention and diagnosis of congenital anomalies in diabetic pregnancies. Clin Perinatol. 1993;20(3):533–47.
Pedersen J. Blood sugar of newborn infants. MD thesis. Copenhagen: Danish Science Press; 1952.
Bernstein IM, Catalano PM. Influence of fetal fat on the ultrasound estimation of fetal weight in diabetic mothers. Obstet Gynecol. 1992;79(4):561–3.
Pettitt DJ, Knowler WC, Bennett PH, Aleck KA, Baird HR. Obesity in offspring of diabetic Pima Indian women despite normal birth weight. Diabetes Care. 1987;10(1):76–80.
Committee on Practice B-O. Practice Bulletin No. 137: gestational diabetes mellitus. Obstetrics and gynecology. 2013;122(2 Pt 1):406–16.
Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Aktary WM, et al. Screening and diagnosing gestational diabetes mellitus. Evid Rep Technol Assess. 2012;210:1–327.
International Association of D, Pregnancy Study Groups Consensus P, Metzger BE, Gabbe SG, Persson B, Buchanan TA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes care. 2010;33(3):676-82.
American DA. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36 Suppl 1:S67–74.
National Institutes of Health consensus development conference statement: diagnosing gestational diabetes mellitus, March 4-6, 2013. Obstetrics and gynecology. 2013;122(2 Pt 1):358-69.
Hartling L, Dryden DM, Guthrie A, Muise M, Vandermeer B, Donovan L. Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research. Ann Intern Med. 2013;159(2):123–9.
American DA. Standards of medical care in diabetes–2013. Diabetes Care. 2013;36 Suppl 1:S11–66.
Conway DL, Gonzales O, Skiver D. Use of glyburide for the treatment of gestational diabetes: the San Antonio experience. J Matern Fetal Neonatal Med. 2004;15(1):51–5.
Moore LE, Clokey D, Rappaport VJ, Curet LB. Metformin compared with glyburide in gestational diabetes: a randomized controlled trial. Obstet Gynecol. 2010;115(1):55–9.
Mazze RS, Shamoon H, Pasmantier R, Lucido D, Murphy J, Hartmann K, et al. Reliability of blood glucose monitoring by patients with diabetes mellitus. Am J Med. 1984;77(2):211–7.
Buchanan TA, Kjos SL, Montoro MN, Wu PY, Madrilejo NG, Gonzalez M, et al. Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes. Diabetes Care. 1994;17(4):275–83.
Practice ACOG. Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 60, March 2005. Pregestational diabetes mellitus. Obstet Gynecol. 2005;105(3):675–85.
Kline GA, Edwards A. Antepartum and intra-partum insulin management of type 1 and type 2 diabetic women: Impact on clinically significant neonatal hypoglycemia. Diabetes Res Clin Pract. 2007;77(2):223–30.
De Groot L, Abalovich M, Alexander EK, Amino N, Barbour L, Cobin RH, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(8):2543–65.
American DA. Gestational diabetes mellitus. Diabetes Care. 2004;27 Suppl 1:S88–90.
Metzger BE, Buchanan TA, Coustan DR, de Leiva A, Dunger DB, Hadden DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 2007;30 Suppl 2:S251–60.
Catalano PM, Vargo KM, Bernstein IM, Amini SB. Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Am J Obstet Gynecol. 1991;165(4 Pt 1):914–9.
Kjos SL, Buchanan TA, Greenspoon JS, Montoro M, Bernstein GS, Mestman JH. Gestational diabetes mellitus: the prevalence of glucose intolerance and diabetes mellitus in the first two months post partum. Am J Obstet Gynecol. 1990;163(1 Pt 1):93–8.
Retnakaran R, Qi Y, Connelly PW, Sermer M, Zinman B, Hanley AJ. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab. 2010;95(2):670–7.
Kessous R, Shoham-Vardi I, Pariente G, Sherf M, Sheiner E. An association between gestational diabetes mellitus and long-term maternal cardiovascular morbidity. Heart. 2013;99(15):1118–21.
Retnakaran R, Qi Y, Sermer M, Connelly PW, Hanley AJ, Zinman B. The postpartum cardiovascular risk factor profile of women with isolated hyperglycemia at 1-hour on the oral glucose tolerance test in pregnancy. Nutr Metab Cardiovasc Dis. 2011;21(9):706–12.
Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359(9323):2072–7.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393–403.
Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes care. 1997;20(4):537–44.
Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–50.
Gabbe SG, Landon MB, Warren-Boulton E, Fradkin J. Promoting health after gestational diabetes: a National Diabetes Education Program call to action. Obstet Gynecol. 2012;119(1):171–6.
Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115(3):e290–6.
Kim C, Berger DK, Chamany S. Recurrence of gestational diabetes mellitus: a systematic review. Diabetes Care. 2007;30(5):1314–9.
Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception. 2011;84(5):478–85.
Kitzmiller JL, Block JM, Brown FM, Catalano PM, Conway DL, Coustan DR, et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care. 2008;31(5):1060–79.
Rasmussen KM, Yaktine AL, editors. Weight gain during pregnancy: reexamining the guidelines. Washington, DC; 2009.
Duley L, Henderson-Smart D, Knight M, King J. Antiplatelet drugs for prevention of pre-eclampsia and its consequences: systematic review. BMJ. 2001;322(7282):329–33.
Cheschier N, Bulletins-Obstetrics ACoP. ACOG practice bulletin. Neural tube defects. Number 44, July 2003. (Replaces committee opinion number 252, March 2001). International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2003;83(1):123-33.
Coustan DR, Widness JA, Carpenter MW, Rotondo L, Pratt DC, Oh W. Should the fifty-gram, one-hour plasma glucose screening test for gestational diabetes be administered in the fasting or fed state? Am J Obstet Gynecol. 1986;154(5):1031–5.
Medical JL. Management of pregnancy complicated by diabetes. 4th ed. Alexandria, VA: American Diabetes Association; 2009.
Thomas H. Medications and Mothers’ Milk: Hale Publishing. Texas: Amarillo; 2008.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Larson, L., Carpenter, M. (2015). Diabetes and Pregnancy. In: Rosene-Montella, K. (eds) Medical Management of the Pregnant Patient. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1244-1_4
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1244-1_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-1243-4
Online ISBN: 978-1-4614-1244-1
eBook Packages: MedicineMedicine (R0)